-
2
-
-
1642270492
-
Breast Cancer Recurrence: Follow Up after Treatment for Primary Breast Cancer
-
Hiramanek N. Breast Cancer Recurrence: Follow Up after Treatment for Primary Breast Cancer. Postgrad Med J 2004; 80(941):172-6.
-
(2004)
Postgrad Med J
, vol.80
, Issue.941
, pp. 172-176
-
-
Hiramanek, N.1
-
3
-
-
4444226062
-
-
London: National Collaborating Centre for Primary Care/ University of Sheffield, National Institute for Clinical Excellence, Accessed on 11.1.2009
-
McIntosh A, Shaw C, Evans G, A. Clinical Guidelines and Evidence Review for the Classification and Care of Women at Risk of Familial Breast Cancer, London: National Collaborating Centre for Primary Care/ University of Sheffield, National Institute for Clinical Excellence 2004; 109-38. www.nice.org.uk. Accessed on 11.1.2009.
-
(2004)
A. Clinical Guidelines and Evidence Review for the Classification and Care of Women at Risk of Familial Breast Cancer
, pp. 109-138
-
-
McIntosh, A.1
Shaw, C.2
Evans, G.3
-
4
-
-
67749086458
-
Review: Breast Cancer is Associated with a Family History of the Disease in First Degree Relatives. Evidence-Based Medicine
-
Janowsky EC. Review: Breast Cancer is Associated with a Family History of the Disease in First Degree Relatives. Evidence-Based Medicine ACP J Club 2002; 136(3): 115.
-
(2002)
ACP J Club
, vol.136
, Issue.3
, pp. 115
-
-
Janowsky, E.C.1
-
5
-
-
67749103736
-
-
American Cancer Society, Inc. Detailed Guide: Breast Cancer. What Are the Key Statistics for Breast Cancer? http://www.cancer.org/docroot/CRI/ content/CRI_2_4_1X_What_are_the_key_statistics_for_ breastn_cancer_5.asp?sitearea= Accessed on 26.11.2008.
-
American Cancer Society, Inc. Detailed Guide: Breast Cancer. What Are the Key Statistics for Breast Cancer? http://www.cancer.org/docroot/CRI/ content/CRI_2_4_1X_What_are_the_key_statistics_for_ breastn_cancer_5.asp?sitearea= Accessed on 26.11.2008.
-
-
-
-
6
-
-
0037169354
-
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
-
Venkitaraman AR. Cancer Susceptibility and the Functions of BRCA1 and BRCA2. Cell 2002; 108(2): 171-82.
-
(2002)
Cell
, vol.108
, Issue.2
, pp. 171-182
-
-
Venkitaraman, A.R.1
-
7
-
-
0028843102
-
Breast and Ovarian Cancer Incidence in BRCA1-Mutation Carriers. Breast Cancer Linkage Consortium
-
Easton DF, Ford D, Bishop DT. Breast and Ovarian Cancer Incidence in BRCA1-Mutation Carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 1995; 56(1): 265-71.
-
(1995)
Am J Hum Genet
, vol.56
, Issue.1
, pp. 265-271
-
-
Easton, D.F.1
Ford, D.2
Bishop, D.T.3
-
8
-
-
33748612708
-
Breast Cancer Risk Factors and Stage at Presentation
-
Al Saad SK, A Jalal A. Breast Cancer Risk Factors and Stage at Presentation. Bahrain Medical Bulletin 2006; 28(3): 111-5.
-
(2006)
Bahrain Medical Bulletin
, vol.28
, Issue.3
, pp. 111-115
-
-
Saad, A.1
SK, A.2
Jalal, A.3
-
9
-
-
0030914999
-
Family History and the Risk of Breast Cancer: A Systematic Review and Meta-Analysis
-
Pharoah PD, Day NE, Duffy S. Family History and the Risk of Breast Cancer: A Systematic Review and Meta-Analysis. Int J Cancer 1997; 7: 800-9.
-
(1997)
Int J Cancer
, vol.7
, pp. 800-809
-
-
Pharoah, P.D.1
Day, N.E.2
Duffy, S.3
-
10
-
-
67749114375
-
BRCA1/BRCA2 Mutations: Treatment and Counseling for Breast Cancer
-
October 22-26, Boston, Massachusetts, Accessed on 26.11.2008
-
Salem CL. BRCA1/BRCA2 Mutations: Treatment and Counseling for Breast Cancer. American Society for Therapeutic Radiology and Oncology 42nd Annual Meeting CME; October 22-26, 2000, Boston, Massachusetts. http://www.medscape.com/viewarticle/420294. Accessed on 26.11.2008.
-
(2000)
American Society for Therapeutic Radiology and Oncology 42nd Annual Meeting CME
-
-
Salem, C.L.1
-
11
-
-
0028085548
-
Risk Factors for Breast Cancer. Case-control Study Results
-
Azzena A, Zen T, Ferrara A, et al. Risk Factors for Breast Cancer. Case-control Study Results. Eur J Gynaecol Oncol 1994; 15(5): 386-92.
-
(1994)
Eur J Gynaecol Oncol
, vol.15
, Issue.5
, pp. 386-392
-
-
Azzena, A.1
Zen, T.2
Ferrara, A.3
-
12
-
-
58749091606
-
-
Metcalfe KA, Finch A, Poll A, Horsman D, et al. Breast Cancer Risks in Women with A Family History of Breast or Ovarian Cancer Who have Tested Negative for a BRCA1 or BRCA2 Mutation. Br J Cancer 2009; 27; 100(2): 421-5.
-
Metcalfe KA, Finch A, Poll A, Horsman D, et al. Breast Cancer Risks in Women with A Family History of Breast or Ovarian Cancer Who have Tested Negative for a BRCA1 or BRCA2 Mutation. Br J Cancer 2009; 27; 100(2): 421-5.
-
-
-
-
13
-
-
33646394043
-
BRCA1, BRCA2 and TP53 Mutations in Very Early-onset Breast Cancer with Associated Risks to Relatives
-
Lalloo F, Varley J, Moran A, et al. BRCA1, BRCA2 and TP53 Mutations in Very Early-onset Breast Cancer with Associated Risks to Relatives. European Journal of Cancer 2006; 42(8): 1143-50.
-
(2006)
European Journal of Cancer
, vol.42
, Issue.8
, pp. 1143-1150
-
-
Lalloo, F.1
Varley, J.2
Moran, A.3
-
14
-
-
0023714136
-
Family History as a Risk Factor for Early Onset Breast Cancer
-
Lynch HT, Watson P, Conway T, et al. Family History as a Risk Factor for Early Onset Breast Cancer. Breast Cancer Res Treat. 1988; 11(3): 263-7.
-
(1988)
Breast Cancer Res Treat
, vol.11
, Issue.3
, pp. 263-267
-
-
Lynch, H.T.1
Watson, P.2
Conway, T.3
-
17
-
-
0141499911
-
The CYP3A4*1B Variant Is Related to the Onset of Puberty, A Known Risk Factor for the Development of Breast Cancer
-
Kadlubar FF, Berkowitz GS, Delongchamp RR, et al. The CYP3A4*1B Variant Is Related to the Onset of Puberty, A Known Risk Factor for the Development of Breast Cancer. Cancer Epidemiol Biomarkers Prev 2003; 12(4): 327-31.
-
(2003)
Cancer Epidemiol Biomarkers Prev
, vol.12
, Issue.4
, pp. 327-331
-
-
Kadlubar, F.F.1
Berkowitz, G.S.2
Delongchamp, R.R.3
-
19
-
-
2342584146
-
Staging Reproductive Aging: A Comparison of Proposed Bleeding Criteria for the Menopausal Transition
-
Lisabeth LD, Harlow SD, Gillespie B, et al. Staging Reproductive Aging: A Comparison of Proposed Bleeding Criteria for the Menopausal Transition. Menopause 2004; 11(2): 186-97.
-
(2004)
Menopause
, vol.11
, Issue.2
, pp. 186-197
-
-
Lisabeth, L.D.1
Harlow, S.D.2
Gillespie, B.3
-
20
-
-
0025092513
-
-
Ewertz M, Duffy SW, Adami HO, et al. Age at First Birth, Parity and Risk of Breast Cancer: a Meta-analysis of 8 Studies from the Nordic Countries. Int J Cancer 1990; 15; 46(4): 597-603.
-
Ewertz M, Duffy SW, Adami HO, et al. Age at First Birth, Parity and Risk of Breast Cancer: a Meta-analysis of 8 Studies from the Nordic Countries. Int J Cancer 1990; 15; 46(4): 597-603.
-
-
-
-
21
-
-
0029776854
-
Age at First Full-term Pregnancy, Lactation and Parity and Risk of Breast Cancer: A Case-control Study in Spain
-
Ramon JM, Escriba JM, Casas I, et al. Age at First Full-term Pregnancy, Lactation and Parity and Risk of Breast Cancer: A Case-control Study in Spain. Eur J Epidemiol 1996; 12(5): 449-53.
-
(1996)
Eur J Epidemiol
, vol.12
, Issue.5
, pp. 449-453
-
-
Ramon, J.M.1
Escriba, J.M.2
Casas, I.3
-
22
-
-
0002116740
-
-
Newcomb PA, Storer BE, Longnecker MP, et al. Lactation and a Reduced Risk of Premenopausal Breast Cancer. N Engl J Med 1994; 13; 330(2): 81-7.
-
Newcomb PA, Storer BE, Longnecker MP, et al. Lactation and a Reduced Risk of Premenopausal Breast Cancer. N Engl J Med 1994; 13; 330(2): 81-7.
-
-
-
-
23
-
-
0036846452
-
Use of Oral Contraceptives and Breast Cancer Risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study
-
Kumle M, Weiderpass E, Braaten T, et al. Use of Oral Contraceptives and Breast Cancer Risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study. Cancer Epidemiol Biomarkers Prev 2002; 11(11): 1375-81.
-
(2002)
Cancer Epidemiol Biomarkers Prev
, vol.11
, Issue.11
, pp. 1375-1381
-
-
Kumle, M.1
Weiderpass, E.2
Braaten, T.3
-
24
-
-
0242390079
-
Breast Cancer and Hormonal Contraceptives
-
Collaborative Group on Hormonal Factors in Breast Cancer
-
Collaborative Group on Hormonal Factors in Breast Cancer. Breast Cancer and Hormonal Contraceptives Lancet 1996; 347; 9017: 1713-27.
-
(1996)
Lancet
, vol.347
, Issue.9017
, pp. 1713-1727
-
-
-
25
-
-
0035010650
-
Hormone Replacement Therapy and the Sensitivity and Specificity of Breast Cancer Screening: A Review
-
Banks E. Hormone Replacement Therapy and the Sensitivity and Specificity of Breast Cancer Screening: A Review. J Med Screen 2001; 8(1): 29-34.
-
(2001)
J Med Screen
, vol.8
, Issue.1
, pp. 29-34
-
-
Banks, E.1
-
26
-
-
0037830132
-
-
Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: the Women's Health Initiative Randomized Trial. JAMA 2003; 25; 289(24): 3243-53.
-
Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: the Women's Health Initiative Randomized Trial. JAMA 2003; 25; 289(24): 3243-53.
-
-
-
-
27
-
-
0030798249
-
Breast Cancer and Hormone Replacement Therapy
-
Collaborative Group on Hormonal Factors in Breast Cancer
-
Collaborative Group on Hormonal Factors in Breast Cancer. Breast Cancer and Hormone Replacement Therapy. Lancet 1997; 350; 9084: 1047-59.
-
(1997)
Lancet
, vol.350
, Issue.9084
, pp. 1047-1059
-
-
|